In the published article, there was an error in the Funding statement. The following funding information is missing: “We acknowledge support by the Open Access Publication Fund of the University of Freiburg.” The correct Funding statement appears below.
Statements
Funding
This work was supported by the Deutsche Forsch-ungsgemeinschaft (DFG) IMPATH SFB1160/2_B5. BG receives support by the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984, and RESIST – EXC 2155 – Project ID 390874280); by the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD; and by the German Federal Ministry of Education and Research (BMBF) through a grant to the German Auto-Immunity Network (GAIN), grant code 01GM1910A. HH is funded by the Deutsche Forschungsgemeinschaft (DFG) through HE2526/9-1. MK is supported by the Deutsche Forschungsgemeinschaft (DFG) SFB1160_2 as clinician scientist associated to IMM-PACT-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
cytotoxic T-lymphocyte antigen 4 (CTLA-4), immunodeficencies, immune dysregulation, inborn errors of immunity (IEI), disease modifiers
Citation
Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz H-M, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L and Grimbacher B (2023) Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?. Front. Immunol. 14:1226814. doi: 10.3389/fimmu.2023.1226814
Received
22 May 2023
Accepted
23 May 2023
Published
02 June 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Krausz, Mitsuiki, Falcone, Komp, Posadas-Cantera, Lorenz, Litzman, Wolff, Kanariou, Heinkele, Speckmann, Häcker, Hengel, Gámez-Díaz and Grimbacher.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bodo Grimbacher, bodo.grimbacher@uniklinik-freiburg.de
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.